It may be possible to request a waiver of in-vivo testing for all the strengths of this
product provided that the appropriate documentation regarding high solubility, high
permeability and rapid dissolution as detailed in the Guidance for Industry: Waiver
of In Vivo Bioavailability and Bioequivalence for Immediate – Release Solid Oral
Dosage Forms Based on the Biopharmaceutics Classification System is submitted
in the application. You may use information contained in the approved labeling of
the reference product. Peer reviewed articles may not contain the necessary details
of the testing for the Agency to make a judgment regarding the quality of the
studies. A decision regarding the acceptability of the waiver request can only be
made upon review of the data submitted in the application.